MarketPulse

warrants

27 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Calidi Biotherapeutics Raises $6M in Public Offering, Exercises Full Warrant Overallotment

Calidi Biotherapeutics closed a $6 million underwritten public offering, issuing 12.1 million shares and Series J, K, L warrants with $0.50 exercise prices.
CLDIwarrantspublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

AIM ImmunoTech Closes $1.8M Rights Offering to Fund Pancreatic Cancer Drug

AIM ImmunoTech closes $1.8M rights offering to advance Ampligen immunotherapy development for late-stage pancreatic cancer treatment.
AIMclinical trialswarrants
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Calidi Biotherapeutics Launches Public Offering to Bolster Growth

Calidi Biotherapeutics launches underwritten public offering of common stock and warrants, with Ladenburg Thalmann managing the raise for working capital and corporate purposes.
CLDIwarrantspublic offering
BenzingaBenzinga··Globe Newswire

AIM ImmunoTech Raises $1.8M Through Rights Offering as Biotech Seeks Capital

AIM ImmunoTech raises $1.8M through rights offering expiring March 3, 2026, providing working capital for ongoing immunotherapy operations.
AIMwarrantscapital raise
BenzingaBenzinga··Prnewswire

Juggernaut Exploration Secures C$10M Through Flow-Through Private Placement

Juggernaut Exploration raises C$10M through flow-through private placement to fund exploration of its Big One Gold Project in British Columbia's Golden Triangle.
SFSFBSFpBSFpCSFpDbought dealprivate placement
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bimergen Energy to List on NYSE American After $13.6M Offering

Bimergen Energy prices $13.6M IPO at $4 per share, listing on NYSE American February 20. Proceeds fund battery energy storage projects.
BESSwarrantspublic offering
BenzingaBenzinga··Globe Newswire

Liminatus Pharma Prices $4M Share Offering to Fund Immuno-Oncology Pipeline

Liminatus Pharma prices $4M share offering to fund immuno-oncology pipeline development, specifically advancing CD47-blockade therapeutic programs.
LIMNLIMNWwarrantspublic offering